How does long-acting growth hormone compare to daily shots for kids with Growth Hormone Deficiency?
Long-acting growth hormone is a clinically effective alternative to daily injections for children with growth hormone deficiency. These formulations allow for extended dosing intervals, which helps caregivers manage treatment and improves adherence, especially when children are reluctant to get daily shots 1. The FDA has approved specific long-acting options like Ngenla for pediatric patients aged 3 and older with growth failure due to low growth hormone levels 2.
What the research says
Studies show that long-acting growth hormone promotes linear growth in children with growth hormone deficiency with a safety profile comparable to daily recombinant human GH therapy 1. A meta-analysis of randomized controlled trials found that long-acting formulations resulted in a significant increase in BMI scores over 12 months, whereas daily GH did not show a similar change in that metric 3. This suggests potential differences in how body composition changes between the two treatment types over time.
What to ask your doctor
- How often can my child take long-acting growth hormone compared to daily shots?
- Are there specific long-acting options approved for my child's age group?
- What are the differences in side effects or growth patterns between long-acting and daily growth hormone?
- How might long-acting growth hormone affect my child's body mass index compared to daily treatment?
This question is drawn from common patient questions about Diabetes & Endocrinology and answered using cited medical research. We do not provide individualized advice.